Farrokh-Siar L, Rezai K A, Semnani R T, Patel S C, Ernest J T, van Seventer G A
Department of Ophthalmology and Visual Science, University of Chicago, 939 East 57th Street, Chicago, IL 60637, USA.
Graefes Arch Clin Exp Ophthalmol. 1999 Nov;237(11):934-9. doi: 10.1007/s004170050389.
The suppressive effect of human fetal retinal pigment epithelium (HFRPE) on the activation of human CD4(+) and CD8(+) T-cells was evaluated in vitro.
Pure populations of CD4(+) and CD8(+) T-cells were isolated from human peripheral blood-derived buffy coats by negative immunomagnetic selection. The purity of the cells was examined by flow cytometry using anti-CD3-FITC, anti-CD4-FITC, anti-CD8-PE, and anti-CD20-PE mAbs. HFRPE cells were isolated from fetal eyes and pure cultures were obtained. The effect of normal or IFN-gamma-activated HFRPE cells at early (P3) or late (P6) passages on the activation of CD4(+) and CD8(+) T-cells was assessed in two different T-cell activation assays. In both activation models anti-CD3 mAb (OKT3) provided the antigen-specific signal. The secondary signal for the activation of CD4(+) and CD8(+) T-cells was provided with anti-CD18 mAb (TS1/18) and anti-CD28 mAb (9.3) in the first and the second assay respectively. Cross-linking of these soluble mAbs was performed with sheep-anti-mouse IgG-coated latex beads. The T-cell activation was determined by cell proliferation measured by [(3)H]thymidine incorporation. In each activation assay T-cells were incubated with HFRPE cells in a ratio of T-cells to HFRPE of 1:1 or 1:4.
CD4(+) and CD8(+) T-cells were activated by cross-linking CD3 and CD18 in the first assay (CD3/CD18) and CD3 and CD28 in the second assay (CD3/CD28). In both assays HFRPE inhibited the activation of CD4(+) and CD8(+) T-cells. IFN-gamma-activated HFRPE cells totally suppressed the T-cell activation at a 1:1 ratio. This suppressive effect was weaker at lower cell ratios. Some donor variation was observed in the inhibition at the lower cell ratios, especially for the inhibition of CD8(+) T-cell activation with anti-CD3/CD18. The passaging of HFRPE cells did not alter their suppressive effect on CD4(+) and CD8(+) T-cells.
HFRPE cells suppressed the activation of both CD4(+) and CD8(+) T-cells in vitro. These findings suggest that RPE-induced immune suppression may play a significant role in maintaining immune privilege in the subretinal space.
在体外评估人胎儿视网膜色素上皮(HFRPE)对人CD4(+)和CD8(+) T细胞活化的抑制作用。
通过阴性免疫磁珠分选从人外周血来源的血沉棕黄层中分离出纯的CD4(+)和CD8(+) T细胞群体。使用抗CD3-FITC、抗CD4-FITC、抗CD8-PE和抗CD20-PE单克隆抗体通过流式细胞术检测细胞纯度。从胎儿眼睛中分离出HFRPE细胞并获得纯培养物。在两种不同的T细胞活化试验中评估早期(P3)或晚期(P6)传代的正常或IFN-γ活化的HFRPE细胞对CD4(+)和CD8(+) T细胞活化的影响。在两种活化模型中,抗CD3单克隆抗体(OKT3)提供抗原特异性信号。在第一个试验中,抗CD18单克隆抗体(TS1/18)为CD4(+)和CD8(+) T细胞活化提供第二信号,在第二个试验中,抗CD28单克隆抗体(9.3)提供第二信号。这些可溶性单克隆抗体的交联用羊抗小鼠IgG包被的乳胶珠进行。通过[³H]胸苷掺入法测量细胞增殖来确定T细胞活化。在每个活化试验中,T细胞与HFRPE细胞以T细胞与HFRPE细胞1:1或1:4的比例孵育。
在第一个试验(CD3/CD18)中,通过交联CD3和CD18激活CD4(+)和CD8(+) T细胞,在第二个试验(CD3/CD28)中,通过交联CD3和CD28激活CD4(+)和CD8(+) T细胞。在两个试验中,HFRPE均抑制CD4(+)和CD8(+) T细胞的活化。IFN-γ活化的HFRPE细胞以1:1的比例完全抑制T细胞活化。在较低细胞比例下,这种抑制作用较弱。在较低细胞比例下观察到一些供体差异,特别是在用抗CD3/CD18抑制CD8(+) T细胞活化方面。HFRPE细胞传代未改变其对CD4(+)和CD8(+) T细胞活化的抑制作用。
HFRPE细胞在体外抑制CD4(+)和CD8(+) T细胞的活化。这些发现表明,视网膜色素上皮诱导的免疫抑制可能在维持视网膜下间隙的免疫赦免中起重要作用。